Sirt1 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Sirt1 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Sirt1 Rat Pre-designed siRNA Set A contains three designed siRNAs for Sirt1 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

SIRT2 Human Pre-designed siRNA Set A contains three designed siRNAs for SIRT2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Sirt2 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Sirt2 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Sirt2 Rat Pre-designed siRNA Set A contains three designed siRNAs for Sirt2 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

SIRT2-IN-12 (Compound 3) is a SIRT2 inhibitor with a IC50 value of 50 μM[1].

SIRT2-IN-14 (Compound 78) is a selectve inhibitor for SIRT2 with an IC50 of 0.196 μM[1].

SIRT3 activator 1 (Compound 5v) is a SIRT3 activator. SIRT3 activator 1 selectively elevates SIRT3 expression, leading to the upregulation of SOD2 and OPA1 expression, effectively preventing mitochondrial dysfunction, mitigating oxidative stress, and preserving cardiomyocyte viability. SIRT3 activator 1 can be used for research of cardiovascular diseases[1].

SIRT3 Human Pre-designed siRNA Set A contains three designed siRNAs for SIRT3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Sirt3 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Sirt3 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Sirt3 Rat Pre-designed siRNA Set A contains three designed siRNAs for Sirt3 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

SIRT4 Human Pre-designed siRNA Set A contains three designed siRNAs for SIRT4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SIRT4-IN-1 (compound 69) is selective sirtuin 4 (Sirt4) inhibitor with an IC50 of 16 μM.SIRT4-IN-1 shows no relevant effects on other sirtuin isoforms[1].

SIRT5 Human Pre-designed siRNA Set A contains three designed siRNAs for SIRT5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Sirt5 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Sirt5 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Sirt5 Rat Pre-designed siRNA Set A contains three designed siRNAs for Sirt5 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

SIRT6 Human Pre-designed siRNA Set A contains three designed siRNAs for SIRT6 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Sirt6 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Sirt6 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Sirt6 Rat Pre-designed siRNA Set A contains three designed siRNAs for Sirt6 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

SIRT7 Human Pre-designed siRNA Set A contains three designed siRNAs for SIRT7 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Sirt7 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Sirt7 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Sirt7 Rat Pre-designed siRNA Set A contains three designed siRNAs for Sirt7 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

SIT1 Human Pre-designed siRNA Set A contains three designed siRNAs for SIT1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SIVA1 Human Pre-designed siRNA Set A contains three designed siRNAs for SIVA1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SIX1 Human Pre-designed siRNA Set A contains three designed siRNAs for SIX1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SIX2 Human Pre-designed siRNA Set A contains three designed siRNAs for SIX2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SIX3 Human Pre-designed siRNA Set A contains three designed siRNAs for SIX3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SIX4 Human Pre-designed siRNA Set A contains three designed siRNAs for SIX4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SIX5 Human Pre-designed siRNA Set A contains three designed siRNAs for SIX5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SIX6 Human Pre-designed siRNA Set A contains three designed siRNAs for SIX6 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SJH1-51B is a potent PROTAC degrader of BRD4. SJH1-51B has anti-tumor effect[1].

SJH1-62B is a proteolysis targeting chimera (PROTAC) that can target the androgen receptor (AR)[1].

SKA1 Human Pre-designed siRNA Set A contains three designed siRNAs for SKA1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SKA2 Human Pre-designed siRNA Set A contains three designed siRNAs for SKA2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SKA3 Human Pre-designed siRNA Set A contains three designed siRNAs for SKA3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SKAP1 Human Pre-designed siRNA Set A contains three designed siRNAs for SKAP1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SKAP2 Human Pre-designed siRNA Set A contains three designed siRNAs for SKAP2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SKI Human Pre-designed siRNA Set A contains three designed siRNAs for SKI gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SKIL Human Pre-designed siRNA Set A contains three designed siRNAs for SKIL gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SKLB-163 is an orally active inhibitor for Rho GDP-dissociation (RhoGDI). SKLB-163 inhibits highly expressed RhoGDI tumor cell proliferation and migration, and increases radiosensitivity of tumor cells. SKLB-163 induces cancer cell Apoptosis[1][2].

SKOR1 Human Pre-designed siRNA Set A contains three designed siRNAs for SKOR1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SKOR2 Human Pre-designed siRNA Set A contains three designed siRNAs for SKOR2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SKP1 Human Pre-designed siRNA Set A contains three designed siRNAs for SKP1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SKP2 Human Pre-designed siRNA Set A contains three designed siRNAs for SKP2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Skyrin is an anthraquinone compound that can be isolated from almond fruit. Skyrin is a receptor-selective glucagon antagonist. Skyrin can inhibit the growth of tumor cells[1][2].

SL antagonist 1 (Compound D12) is strigolactones antagonists and can strongly interact with SL receptor proteins.SL antagonist 1 can combat root-parasitic weed infestations. SL antagonist 1 has no side effects on the germination or seedling growth[1].

SLA Human Pre-designed siRNA Set A contains three designed siRNAs for SLA gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SLA2 Human Pre-designed siRNA Set A contains three designed siRNAs for SLA2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.